Fibroblast‐growth‐factor‐23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibroblast‐growth‐factor‐23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes
Authors
Keywords
-
Journal
ESC Heart Failure
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-17
DOI
10.1002/ehf2.13020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME‐CHF trial
- (2020) Robert Stöhr et al. EUROPEAN JOURNAL OF HEART FAILURE
- Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction
- (2020) Julio A. Chirinos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction
- (2019) Prathap Kanagala et al. JACC-Cardiovascular Imaging
- How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
- (2019) Burkert Pieske et al. EUROPEAN HEART JOURNAL
- Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
- (2019) Prathap Kanagala et al. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
- FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis
- (2019) Ineke Böckmann et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fibroblast Growth Factor‐23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA
- (2018) Mohamed Faher Almahmoud et al. Journal of the American Heart Association
- Symptom Onset in Aortic Stenosis
- (2017) Anvesha Singh et al. JACC-Cardiovascular Imaging
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Six-minute walk test in moderate to severe heart failure with preserved ejection fraction: Useful for functional capacity assessment?
- (2016) Patricia Palau et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
- (2016) Valentin David et al. KIDNEY INTERNATIONAL
- Heart Failure with Preserved Ejection Fraction
- (2016) Margaret M. Redfield NEW ENGLAND JOURNAL OF MEDICINE
- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
- (2015) Alexander Grabner et al. Cell Metabolism
- Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction
- (2015) Lorenz Koller et al. Circulation-Heart Failure
- Fibroblast growth factor 23 (FGF23) and mortality: The Ludwigshafen Risk and Cardiovascular Health Study
- (2014) Vincent M. Brandenburg et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor-23 and Cardiovascular Disease in the General Population
- (2014) Bryan Kestenbaum et al. Circulation-Heart Failure
- Heart failure with preserved ejection fraction: a clinical dilemma
- (2014) M. Komajda et al. EUROPEAN HEART JOURNAL
- Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease
- (2014) Jacob A. Udell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD
- (2014) G. S. Di Marco et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women
- (2013) Myles Wolf et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure
- (2011) Max Plischke et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now